A preclinical study detailed that treatment with anti-PD-1 therapy induced macrophage and microglia polarization towards a proinflammatory phenotype in glioma of CD8-/- mice, suggesting that the therapeutic effect of PD-1 blockade may be due to innate rather than adaptive immune system function (28). The gene discussed is PDCD1; the disease is glioma.